CoImmune, Inc. Appoints Michael Fekete and Greg Tibbitts to its Board of Directors
DURHAM, N.C., July 06, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company that will redefine cancer treatment using best-in-class yet more affordable